HABIT-ILE 在慢性卒中成人中的随机对照试验
这项随机对照试验纳入 46 例慢性偏瘫性卒中成人,比较 2 周(50 小时)HABIT-ILE 营地项目与继续常规神经康复(平均 4 小时 36 分钟)的效果。结果显示 HABIT-ILE 组在双手自发使用、上肢运动功能、自我感知能力和参与限制方面优于对照组,但下肢指标未见显著组间差异。
要点
- HABIT-ILE 组在 Ad-AHA Stroke 上 2 周时改善 +6.24% logits、3 个月时 +7.05% logits。
- WMFT 功能能力量表所有 P ≤ 0.041,COPM 表现与满意度 P < 0.001。
- FMA-UE 和 ABILHAND-CS 在 3 个月时组间差异显著(所有 P ≤ 0.033),下肢指标无显著差异。
核心结论
- 在慢性卒中成人中,与对照组相比,HABIT-ILE 显著改善偏瘫上肢的自发双手使用、运动功能、能力和参与限制。
研究设计与样本
- 随机对照试验,46 例慢性偏瘫性卒中成人随机分为 2 周(50 小时,每天 5 小时)HABIT-ILE 营地项目组或同期继续常规神经康复组(平均 4 小时 36 分钟)。
- 在干预前、干预后即刻和干预后 3 个月进行评估,主要结局为 Adult Assisting Hand Assessment Stroke(Ad-AHA Stroke)。
主要发现
- ANCOVA 显示 HABIT-ILE 组在 Ad-AHA Stroke 上 2 周时改善 +6.24% logits、3 个月时 +7.05% logits,组间差异显著。
- WMFT 功能能力量表在 2 周和 3 个月均显示显著组间差异(所有 P ≤ 0.041)。
- COPM 表现和满意度在 2 周和 3 个月均显示显著组间差异(P < 0.001)。
- SIS 手功能在 2 周时组间差异显著(P = 0.003),FMA-UE 和 ABILHAND-CS 在 3 个月时组间差异显著(所有 P ≤ 0.033)。
- 其他结局包括下肢指标未见显著组间差异。
关键数值与推荐
- HABIT-ILE 方案为 2 周、共 50 小时、每天 5 小时的营地设置项目。
- 对照组同期继续常规神经康复,平均时长 4 小时 36 分钟。
- 主要结局 Ad-AHA Stroke 的组间差异在 2 周为 +6.24% logits,3 个月为 +7.05% logits。
临床怎么用
- 对慢性卒中偏瘫成人,可考虑采用 2 周密集 HABIT-ILE 营地项目以改善上肢双手使用、运动功能和参与限制。
- 该干预对下肢指标未见显著改善,临床决策时应结合患者上肢功能目标进行选择。
局限性
- 原文摘要未报告样本量计算、盲法实施、脱落情况等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke rehabilitation guidelines recommend goal-oriented, task-specific, intensive interventions. Yet most programs emphasize upper extremity (UE) recovery, overlooking lower extremities (LEs) and trunk, which are essential for activities of daily living. Consequently, Hand-Arm Bimanual Intensive Therapy Including LEs (HABIT-ILE) represents a promising approach for stroke rehabilitation. OBJECTIVE: This randomized controlled trial aimed to determine the effect of HABIT-ILE and to compare its efficacy with a control group in adults with chronic hemiparetic stroke by promoting greater improvements across the body functions, activity, and participation domains of the International Classification of Functioning, Disability and Health. METHODS: Forty-six adults with hemiparetic chronic stroke were randomized to either a 2-week (50 h, 5 h/day) HABIT-ILE camp-setting program in Brussels, Belgium, or to continue their usual neurorehabilitation (mean = 4 h 36 min) for over the same period. Participants were assessed before, immediately, and at 3 months after intervention using the Adult Assisting Hand Assessment Stroke (Ad-AHA Stroke, primary outcome), the Canadian Occupational Performance Measure (COPM), the Fugl Meyer Assessment for UEs (FMA-UE), the Wolf Motor Function Test (WMFT), the ABILHAND-CS and ACTIVLIM-CS questionnaires, the six-minute walk test, the modified Rankin Scale and the Stroke Impact Scale (SIS). RESULTS: The ANCOVA revealed a significant between-groups difference favoring the HABIT-ILE group (TG), with a time effect observed for the Ad-AHA Stroke (TG: at 2 weeks = +6.24% of logits; at 3 months = +7.05% of logits), WMFT (Functional Ability Scale, all P ≤ 0.041), and COPM (P < 0.001, performance and satisfaction) at both 2 weeks and 3 months. We found a similar significant effect for the SIS (hand function, P = 0.003) at 2 weeks and the FMA-UE and ABILHAND-CS at 3 months (all P ≤ 0.033). We observed no significant between-group differences for the other outcomes, including LEs measures. CONCLUSION: In adults with chronic stroke, HABIT-ILE intervention significantly improved spontaneous bimanual use, motor function, and ability of the paretic UE (both externally rated and self-perceived) and reduced participation restrictions compared with the control group. TRIAL REGISTRATION: This randomized controlled trial was registered on December 11th, 2020, on ClinicalTrials.gov as "HABIT-ILE in Adults With Chronic Stroke (HABIT-ILE Stroke)", with the registration number NCT04664673 (https://clinicaltrials.gov/study/NCT04664673?cond=NCT04664673&rank=).
引用
- Gathy E, Ebner-Karestinos D, Carton de Tournai A, et al. Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) in adults with chronic stroke: a randomized controlled trial. Ann Phys Rehabil Med. 2026. PMID: 42966330. doi:10.1016/j.rehab.2026.102189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。